Current Environment:

Arin K. Greene | Education

Undergraduate School

University of Chicago

1993, Chicago, IL

Graduate School

Translational Research, MMsC

Harvard Medical School

2003, Boston, MA

Medical School

University of Illinois College of Medicine

1997, Chicago, IL


General Surgery

Beth Israel Deaconess Medical Center

2000, Boston, MA


Plastic Surgery

Beth Israel Deaconess Medical Center

2005, Boston, MA


Chief Resident; Plastic Surgery

Beth Israel Deaconess Medical Center

2006, Boston, MA


Angiogenesis Research

Boston Children's Hospital/Harvard Medical School

2003, Boston, MA


Craniofacial/Pediatric Plastic Surgery

Boston Children's Hospital

2007, Boston, MA

Arin K. Greene | Certifications

  • American Board of Plastic Surgery (General)

Arin K. Greene | Professional History

Arin K. Greene, MD, MMSc is a plastic surgeon at Boston Children’s Hospital. Dr. Greene is the Vascular Anomalies and Pediatric Plastic Surgery Endowed Chair and Professor of Surgery at Harvard Medical School. He is a member of the Vascular Anomalies Center, Director of the Lymphedema Program, and Director of the Department of Plastic and Oral Surgery Research Laboratory. During his residency, he completed a Howard Hughes Research Fellowship studying vascular biology in the laboratory of Judah Folkman at Boston Children’s Hospital. During this time, he earned a Masters in Medical Sciences Degree in translational research focused on vascular anomalies. Dr. Greene is past president of the American Association of Pediatric Plastic Surgeons and edited a textbook on pediatric plastic surgery (Pediatric Plastic and Reconstructive Surgery, Thieme Publishing, 2018). His practice is focused on vascular anomalies, lymphedema, ear malformations, breast disorders, pigmented nevi, and general pediatric plastic surgery. Dr. Greene also operates on adults with conditions in his areas of expertise at the Beth Israel Deaconess Medical Center. Dr. Greene’s laboratory is funded by the National Institutes of Health and his major research goal is to develop drugs to treat vascular malformations.

Arin K. Greene | Publications